HEADER ISOMERASE 30-JUN-05 2CXT TITLE CRYSTAL STRUCTURE OF MOUSE AMF / F6P COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOSE-6-PHOSPHATE ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYTOKINE, GPI, PHOSPHOGLUCOSE ISOMERASE, PGI, PHOSPHOHEXOSE COMPND 5 ISOMERASE, PHI, NEUROLEUKIN, NLK; COMPND 6 EC: 5.3.1.9; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.TANAKA,A.HAGA,N.NABA,K.SHIRAIWA,Y.KUSAKABE,K.HASHIMOTO,T.FUNASAKA, AUTHOR 2 H.NAGASE,A.RAZ,K.T.NAKAMURA REVDAT 5 13-MAR-24 2CXT 1 HETSYN REVDAT 4 29-JUL-20 2CXT 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 SITE REVDAT 3 13-JUL-11 2CXT 1 VERSN REVDAT 2 24-FEB-09 2CXT 1 VERSN REVDAT 1 23-MAY-06 2CXT 0 JRNL AUTH N.TANAKA,A.HAGA,N.NABA,K.SHIRAIWA,Y.KUSAKABE,K.HASHIMOTO, JRNL AUTH 2 T.FUNASAKA,H.NAGASE,A.RAZ,K.T.NAKAMURA JRNL TITL CRYSTAL STRUCTURES OF MOUSE AUTOCRINE MOTILITY FACTOR IN JRNL TITL 2 COMPLEX WITH CARBOHYDRATE PHOSPHATE INHIBITORS PROVIDE JRNL TITL 3 INSIGHT INTO STRUCTURE-ACTIVITY RELATIONSHIP OF THE JRNL TITL 4 INHIBITORS JRNL REF J.MOL.BIOL. V. 356 312 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16375918 JRNL DOI 10.1016/J.JMB.2005.11.076 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 171986 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 9078 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 12849 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE SET COUNT : 670 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8832 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 1059 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.79000 REMARK 3 B22 (A**2) : -1.08000 REMARK 3 B33 (A**2) : 1.71000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.39000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.078 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.078 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.056 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.559 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9104 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12320 ; 1.033 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1112 ; 5.281 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1342 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6820 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4696 ; 0.183 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 859 ; 0.090 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.129 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 40 ; 0.083 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5536 ; 0.408 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8916 ; 0.809 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3568 ; 1.351 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3404 ; 2.294 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2CXT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000024747. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 181102 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CACODYLATE, PEG8000, NAACETATE, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 58.01800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -77.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 140 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 259 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 511 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 47 -2.23 71.46 REMARK 500 ASP A 161 -53.09 -132.61 REMARK 500 SER A 185 -50.11 -136.86 REMARK 500 SER A 210 117.45 -164.26 REMARK 500 ASP A 342 113.74 -167.11 REMARK 500 THR A 375 -134.25 -112.08 REMARK 500 GLN A 512 62.30 -158.43 REMARK 500 ASN B 47 -3.57 73.60 REMARK 500 LYS B 57 33.05 -87.15 REMARK 500 ASP B 161 -52.87 -131.42 REMARK 500 SER B 185 -48.95 -138.27 REMARK 500 SER B 210 117.38 -163.69 REMARK 500 ASP B 342 114.26 -168.06 REMARK 500 THR B 375 -135.84 -116.90 REMARK 500 ALA B 390 -62.77 -123.78 REMARK 500 GLN B 512 56.20 -158.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CVP RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT INHIBITOR REMARK 900 RELATED ID: 2CXN RELATED DB: PDB REMARK 900 RELATED ID: 2CXO RELATED DB: PDB REMARK 900 RELATED ID: 2CXP RELATED DB: PDB REMARK 900 RELATED ID: 2CXQ RELATED DB: PDB REMARK 900 RELATED ID: 2CXR RELATED DB: PDB REMARK 900 RELATED ID: 2CXS RELATED DB: PDB REMARK 900 RELATED ID: 2CXU RELATED DB: PDB DBREF 2CXT A 2 557 UNP P06745 G6PI_MOUSE 1 556 DBREF 2CXT B 2 557 UNP P06745 G6PI_MOUSE 1 556 SEQADV 2CXT MET A 1 UNP P06745 INITIATING METHIONINE SEQADV 2CXT SER A 61 UNP P06745 ASN 60 CONFLICT SEQADV 2CXT MET B 1 UNP P06745 INITIATING METHIONINE SEQADV 2CXT SER B 61 UNP P06745 ASN 60 CONFLICT SEQRES 1 A 557 MET ALA ALA LEU THR ARG ASN PRO GLN PHE GLN LYS LEU SEQRES 2 A 557 LEU GLU TRP HIS ARG ALA ASN SER ALA ASN LEU LYS LEU SEQRES 3 A 557 ARG GLU LEU PHE GLU ALA ASP PRO GLU ARG PHE ASN ASN SEQRES 4 A 557 PHE SER LEU ASN LEU ASN THR ASN HIS GLY HIS ILE LEU SEQRES 5 A 557 VAL ASP TYR SER LYS ASN LEU VAL SER LYS GLU VAL MET SEQRES 6 A 557 GLN MET LEU VAL GLU LEU ALA LYS SER ARG GLY VAL GLU SEQRES 7 A 557 ALA ALA ARG ASP ASN MET PHE SER GLY SER LYS ILE ASN SEQRES 8 A 557 TYR THR GLU ASP ARG ALA VAL LEU HIS VAL ALA LEU ARG SEQRES 9 A 557 ASN ARG SER ASN THR PRO ILE LYS VAL ASP GLY LYS ASP SEQRES 10 A 557 VAL MET PRO GLU VAL ASN ARG VAL LEU ASP LYS MET LYS SEQRES 11 A 557 SER PHE CYS GLN ARG VAL ARG SER GLY ASP TRP LYS GLY SEQRES 12 A 557 TYR THR GLY LYS SER ILE THR ASP ILE ILE ASN ILE GLY SEQRES 13 A 557 ILE GLY GLY SER ASP LEU GLY PRO LEU MET VAL THR GLU SEQRES 14 A 557 ALA LEU LYS PRO TYR SER LYS GLY GLY PRO ARG VAL TRP SEQRES 15 A 557 PHE VAL SER ASN ILE ASP GLY THR HIS ILE ALA LYS THR SEQRES 16 A 557 LEU ALA SER LEU SER PRO GLU THR SER LEU PHE ILE ILE SEQRES 17 A 557 ALA SER LYS THR PHE THR THR GLN GLU THR ILE THR ASN SEQRES 18 A 557 ALA GLU THR ALA LYS GLU TRP PHE LEU GLU ALA ALA LYS SEQRES 19 A 557 ASP PRO SER ALA VAL ALA LYS HIS PHE VAL ALA LEU SER SEQRES 20 A 557 THR ASN THR ALA LYS VAL LYS GLU PHE GLY ILE ASP PRO SEQRES 21 A 557 GLN ASN MET PHE GLU PHE TRP ASP TRP VAL GLY GLY ARG SEQRES 22 A 557 TYR SER LEU TRP SER ALA ILE GLY LEU SER ILE ALA LEU SEQRES 23 A 557 HIS VAL GLY PHE ASP HIS PHE GLU GLN LEU LEU SER GLY SEQRES 24 A 557 ALA HIS TRP MET ASP GLN HIS PHE LEU LYS THR PRO LEU SEQRES 25 A 557 GLU LYS ASN ALA PRO VAL LEU LEU ALA LEU LEU GLY ILE SEQRES 26 A 557 TRP TYR ILE ASN CYS TYR GLY CYS GLU THR HIS ALA LEU SEQRES 27 A 557 LEU PRO TYR ASP GLN TYR MET HIS ARG PHE ALA ALA TYR SEQRES 28 A 557 PHE GLN GLN GLY ASP MET GLU SER ASN GLY LYS TYR ILE SEQRES 29 A 557 THR LYS SER GLY ALA ARG VAL ASP HIS GLN THR GLY PRO SEQRES 30 A 557 ILE VAL TRP GLY GLU PRO GLY THR ASN GLY GLN HIS ALA SEQRES 31 A 557 PHE TYR GLN LEU ILE HIS GLN GLY THR LYS MET ILE PRO SEQRES 32 A 557 CYS ASP PHE LEU ILE PRO VAL GLN THR GLN HIS PRO ILE SEQRES 33 A 557 ARG LYS GLY LEU HIS HIS LYS ILE LEU LEU ALA ASN PHE SEQRES 34 A 557 LEU ALA GLN THR GLU ALA LEU MET LYS GLY LYS LEU PRO SEQRES 35 A 557 GLU GLU ALA ARG LYS GLU LEU GLN ALA ALA GLY LYS SER SEQRES 36 A 557 PRO GLU ASP LEU GLU LYS LEU LEU PRO HIS LYS VAL PHE SEQRES 37 A 557 GLU GLY ASN ARG PRO THR ASN SER ILE VAL PHE THR LYS SEQRES 38 A 557 LEU THR PRO PHE ILE LEU GLY ALA LEU ILE ALA MET TYR SEQRES 39 A 557 GLU HIS LYS ILE PHE VAL GLN GLY ILE MET TRP ASP ILE SEQRES 40 A 557 ASN SER PHE ASP GLN TRP GLY VAL GLU LEU GLY LYS GLN SEQRES 41 A 557 LEU ALA LYS LYS ILE GLU PRO GLU LEU GLU GLY SER SER SEQRES 42 A 557 ALA VAL THR SER HIS ASP SER SER THR ASN GLY LEU ILE SEQRES 43 A 557 SER PHE ILE LYS GLN GLN ARG ASP THR LYS LEU SEQRES 1 B 557 MET ALA ALA LEU THR ARG ASN PRO GLN PHE GLN LYS LEU SEQRES 2 B 557 LEU GLU TRP HIS ARG ALA ASN SER ALA ASN LEU LYS LEU SEQRES 3 B 557 ARG GLU LEU PHE GLU ALA ASP PRO GLU ARG PHE ASN ASN SEQRES 4 B 557 PHE SER LEU ASN LEU ASN THR ASN HIS GLY HIS ILE LEU SEQRES 5 B 557 VAL ASP TYR SER LYS ASN LEU VAL SER LYS GLU VAL MET SEQRES 6 B 557 GLN MET LEU VAL GLU LEU ALA LYS SER ARG GLY VAL GLU SEQRES 7 B 557 ALA ALA ARG ASP ASN MET PHE SER GLY SER LYS ILE ASN SEQRES 8 B 557 TYR THR GLU ASP ARG ALA VAL LEU HIS VAL ALA LEU ARG SEQRES 9 B 557 ASN ARG SER ASN THR PRO ILE LYS VAL ASP GLY LYS ASP SEQRES 10 B 557 VAL MET PRO GLU VAL ASN ARG VAL LEU ASP LYS MET LYS SEQRES 11 B 557 SER PHE CYS GLN ARG VAL ARG SER GLY ASP TRP LYS GLY SEQRES 12 B 557 TYR THR GLY LYS SER ILE THR ASP ILE ILE ASN ILE GLY SEQRES 13 B 557 ILE GLY GLY SER ASP LEU GLY PRO LEU MET VAL THR GLU SEQRES 14 B 557 ALA LEU LYS PRO TYR SER LYS GLY GLY PRO ARG VAL TRP SEQRES 15 B 557 PHE VAL SER ASN ILE ASP GLY THR HIS ILE ALA LYS THR SEQRES 16 B 557 LEU ALA SER LEU SER PRO GLU THR SER LEU PHE ILE ILE SEQRES 17 B 557 ALA SER LYS THR PHE THR THR GLN GLU THR ILE THR ASN SEQRES 18 B 557 ALA GLU THR ALA LYS GLU TRP PHE LEU GLU ALA ALA LYS SEQRES 19 B 557 ASP PRO SER ALA VAL ALA LYS HIS PHE VAL ALA LEU SER SEQRES 20 B 557 THR ASN THR ALA LYS VAL LYS GLU PHE GLY ILE ASP PRO SEQRES 21 B 557 GLN ASN MET PHE GLU PHE TRP ASP TRP VAL GLY GLY ARG SEQRES 22 B 557 TYR SER LEU TRP SER ALA ILE GLY LEU SER ILE ALA LEU SEQRES 23 B 557 HIS VAL GLY PHE ASP HIS PHE GLU GLN LEU LEU SER GLY SEQRES 24 B 557 ALA HIS TRP MET ASP GLN HIS PHE LEU LYS THR PRO LEU SEQRES 25 B 557 GLU LYS ASN ALA PRO VAL LEU LEU ALA LEU LEU GLY ILE SEQRES 26 B 557 TRP TYR ILE ASN CYS TYR GLY CYS GLU THR HIS ALA LEU SEQRES 27 B 557 LEU PRO TYR ASP GLN TYR MET HIS ARG PHE ALA ALA TYR SEQRES 28 B 557 PHE GLN GLN GLY ASP MET GLU SER ASN GLY LYS TYR ILE SEQRES 29 B 557 THR LYS SER GLY ALA ARG VAL ASP HIS GLN THR GLY PRO SEQRES 30 B 557 ILE VAL TRP GLY GLU PRO GLY THR ASN GLY GLN HIS ALA SEQRES 31 B 557 PHE TYR GLN LEU ILE HIS GLN GLY THR LYS MET ILE PRO SEQRES 32 B 557 CYS ASP PHE LEU ILE PRO VAL GLN THR GLN HIS PRO ILE SEQRES 33 B 557 ARG LYS GLY LEU HIS HIS LYS ILE LEU LEU ALA ASN PHE SEQRES 34 B 557 LEU ALA GLN THR GLU ALA LEU MET LYS GLY LYS LEU PRO SEQRES 35 B 557 GLU GLU ALA ARG LYS GLU LEU GLN ALA ALA GLY LYS SER SEQRES 36 B 557 PRO GLU ASP LEU GLU LYS LEU LEU PRO HIS LYS VAL PHE SEQRES 37 B 557 GLU GLY ASN ARG PRO THR ASN SER ILE VAL PHE THR LYS SEQRES 38 B 557 LEU THR PRO PHE ILE LEU GLY ALA LEU ILE ALA MET TYR SEQRES 39 B 557 GLU HIS LYS ILE PHE VAL GLN GLY ILE MET TRP ASP ILE SEQRES 40 B 557 ASN SER PHE ASP GLN TRP GLY VAL GLU LEU GLY LYS GLN SEQRES 41 B 557 LEU ALA LYS LYS ILE GLU PRO GLU LEU GLU GLY SER SER SEQRES 42 B 557 ALA VAL THR SER HIS ASP SER SER THR ASN GLY LEU ILE SEQRES 43 B 557 SER PHE ILE LYS GLN GLN ARG ASP THR LYS LEU HET F6P A1601 17 HET GOL A1701 6 HET GOL A1704 6 HET F6P B2601 17 HET GOL B1702 6 HET GOL B1703 6 HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE HETNAM GOL GLYCEROL HETSYN F6P FRUCTOSE-6-PHOSPHATE; 6-O-PHOSPHONO-BETA-D-FRUCTOSE; 6- HETSYN 2 F6P O-PHOSPHONO-D-FRUCTOSE; 6-O-PHOSPHONO-FRUCTOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 F6P 2(C6 H13 O9 P) FORMUL 4 GOL 4(C3 H8 O3) FORMUL 9 HOH *1059(H2 O) HELIX 1 1 ALA A 2 ASN A 7 1 6 HELIX 2 2 ASN A 7 SER A 21 1 15 HELIX 3 3 ALA A 22 LEU A 24 5 3 HELIX 4 4 LYS A 25 ASP A 33 1 9 HELIX 5 5 GLU A 35 PHE A 40 1 6 HELIX 6 6 SER A 61 ARG A 75 1 15 HELIX 7 7 GLY A 76 SER A 86 1 11 HELIX 8 8 LEU A 99 ARG A 104 1 6 HELIX 9 9 VAL A 118 SER A 138 1 21 HELIX 10 10 ILE A 157 SER A 160 5 4 HELIX 11 11 ASP A 161 LEU A 171 1 11 HELIX 12 12 LYS A 172 SER A 175 5 4 HELIX 13 13 ASP A 188 ALA A 197 1 10 HELIX 14 14 THR A 215 LYS A 234 1 20 HELIX 15 15 ASP A 235 LYS A 241 5 7 HELIX 16 16 ASN A 249 GLY A 257 1 9 HELIX 17 17 ASP A 259 GLN A 261 5 3 HELIX 18 18 GLY A 271 SER A 275 5 5 HELIX 19 19 SER A 278 ILE A 280 5 3 HELIX 20 20 GLY A 281 GLY A 289 1 9 HELIX 21 21 GLY A 289 THR A 310 1 22 HELIX 22 22 PRO A 311 LYS A 314 5 4 HELIX 23 23 ASN A 315 CYS A 330 1 16 HELIX 24 24 ASP A 342 HIS A 346 5 5 HELIX 25 25 ARG A 347 GLY A 361 1 15 HELIX 26 26 THR A 385 ALA A 390 5 6 HELIX 27 27 PHE A 391 GLY A 398 1 8 HELIX 28 28 ILE A 416 LYS A 418 5 3 HELIX 29 29 GLY A 419 GLY A 439 1 21 HELIX 30 30 LEU A 441 ALA A 452 1 12 HELIX 31 31 SER A 455 LEU A 463 1 9 HELIX 32 32 PRO A 464 VAL A 467 5 4 HELIX 33 33 THR A 483 ASP A 506 1 24 HELIX 34 34 GLN A 512 GLY A 514 5 3 HELIX 35 35 VAL A 515 GLU A 526 1 12 HELIX 36 36 PRO A 527 GLU A 530 5 4 HELIX 37 37 ASP A 539 ARG A 553 1 15 HELIX 38 38 ASN B 7 SER B 21 1 15 HELIX 39 39 ALA B 22 LEU B 24 5 3 HELIX 40 40 LYS B 25 ASP B 33 1 9 HELIX 41 41 GLU B 35 PHE B 40 1 6 HELIX 42 42 SER B 61 ARG B 75 1 15 HELIX 43 43 GLY B 76 SER B 86 1 11 HELIX 44 44 LEU B 99 ARG B 104 1 6 HELIX 45 45 VAL B 118 SER B 138 1 21 HELIX 46 46 ILE B 157 SER B 160 5 4 HELIX 47 47 ASP B 161 LEU B 171 1 11 HELIX 48 48 LYS B 172 SER B 175 5 4 HELIX 49 49 ASP B 188 ALA B 197 1 10 HELIX 50 50 THR B 215 LYS B 234 1 20 HELIX 51 51 ASP B 235 LYS B 241 5 7 HELIX 52 52 ASN B 249 GLY B 257 1 9 HELIX 53 53 ASP B 259 GLN B 261 5 3 HELIX 54 54 GLY B 271 SER B 275 5 5 HELIX 55 55 SER B 278 ILE B 280 5 3 HELIX 56 56 GLY B 281 GLY B 289 1 9 HELIX 57 57 GLY B 289 THR B 310 1 22 HELIX 58 58 PRO B 311 LYS B 314 5 4 HELIX 59 59 ASN B 315 CYS B 330 1 16 HELIX 60 60 ASP B 342 HIS B 346 5 5 HELIX 61 61 ARG B 347 GLY B 361 1 15 HELIX 62 62 THR B 385 ALA B 390 5 6 HELIX 63 63 PHE B 391 GLY B 398 1 8 HELIX 64 64 ILE B 416 LYS B 418 5 3 HELIX 65 65 GLY B 419 GLY B 439 1 21 HELIX 66 66 LEU B 441 ALA B 452 1 12 HELIX 67 67 SER B 455 VAL B 467 1 13 HELIX 68 68 THR B 483 ASP B 506 1 24 HELIX 69 69 GLN B 512 GLY B 514 5 3 HELIX 70 70 VAL B 515 GLU B 530 1 16 HELIX 71 71 ASP B 539 ARG B 553 1 15 SHEET 1 A 6 SER A 41 ASN A 45 0 SHEET 2 A 6 HIS A 50 ASP A 54 -1 O VAL A 53 N LEU A 42 SHEET 3 A 6 THR A 474 LYS A 481 -1 O VAL A 478 N LEU A 52 SHEET 4 A 6 CYS A 404 GLN A 411 1 N PHE A 406 O ILE A 477 SHEET 5 A 6 THR A 335 PRO A 340 1 N LEU A 339 O ASP A 405 SHEET 6 A 6 ILE A 378 TRP A 380 1 O TRP A 380 N LEU A 338 SHEET 1 B 2 LYS A 112 VAL A 113 0 SHEET 2 B 2 LYS A 116 ASP A 117 -1 O LYS A 116 N VAL A 113 SHEET 1 C 5 ARG A 180 VAL A 184 0 SHEET 2 C 5 ASP A 151 ILE A 155 1 N ILE A 152 O ARG A 180 SHEET 3 C 5 SER A 204 ALA A 209 1 O ILE A 207 N ILE A 155 SHEET 4 C 5 PHE A 243 SER A 247 1 O VAL A 244 N ILE A 208 SHEET 5 C 5 MET A 263 GLU A 265 1 O PHE A 264 N ALA A 245 SHEET 1 D 6 SER B 41 ASN B 45 0 SHEET 2 D 6 HIS B 50 ASP B 54 -1 O VAL B 53 N LEU B 42 SHEET 3 D 6 THR B 474 LYS B 481 -1 O VAL B 478 N LEU B 52 SHEET 4 D 6 CYS B 404 GLN B 411 1 N PHE B 406 O ILE B 477 SHEET 5 D 6 THR B 335 PRO B 340 1 N LEU B 339 O ASP B 405 SHEET 6 D 6 ILE B 378 TRP B 380 1 O ILE B 378 N HIS B 336 SHEET 1 E 2 LYS B 112 VAL B 113 0 SHEET 2 E 2 LYS B 116 ASP B 117 -1 O LYS B 116 N VAL B 113 SHEET 1 F 5 ARG B 180 VAL B 184 0 SHEET 2 F 5 ASP B 151 ILE B 155 1 N ILE B 152 O ARG B 180 SHEET 3 F 5 SER B 204 ALA B 209 1 O ILE B 207 N ILE B 155 SHEET 4 F 5 PHE B 243 SER B 247 1 O VAL B 244 N ILE B 208 SHEET 5 F 5 MET B 263 GLU B 265 1 O PHE B 264 N ALA B 245 CISPEP 1 GLY A 384 THR A 385 0 8.78 CISPEP 2 GLY B 384 THR B 385 0 7.47 CRYST1 69.976 116.036 73.467 90.00 101.67 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014291 0.000000 0.002951 0.00000 SCALE2 0.000000 0.008618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013899 0.00000